MEM 1003, a novel dihydropyridine L-type Ca2+ channel modulator, is a potential therapeutic drug for Alzheimer's disease

被引：0
|
作者：
Lowe, David A.
Rowe, Wayne B.
Tripodi-Murphy, Crista
Yang, Fing
Ahrens, Rosemary
DiSomma, Rachael
Hsu, Cathleen
Kogan, Jeff
Wang, Daguang
Dizon, Marc
Ong, Voon
Murray, Michael
Fraser, Paul
Wesiaway, David
DeVivo, Michael
机构：
来源：
ANNALS OF NEUROLOGY | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [1] MEM 1003, a novel L-type Ca2+ channel modulator, as a potential therapeutic for Alzheimer's disease
    Wang, Daguang
    De Vivo, Michael
    Trippodi-Murphy, Crista
    Kornecook, Tom
    Kogan, Jeff
    Tomhaugh, Geoff
    Deng, Chengjun
    Dizon, Marc
    Ong, Voon
    Murray, Michael
    Rowe, Wayne
    Lowe, David
    ANNALS OF NEUROLOGY, 2006, 60 : S8 - S8
  • [2] MEM 1003, a novel, CNS-Selective L-type Ca2+ channel blocker, is a potential therapeutic agent for CNS disorders
    De Vivo, Michael
    Trippodi-Murphy, Crista
    Kogan, Jeffrey H.
    Tombaugh, Geoffrey C.
    Wang, Daguang
    Ong, Voon S.
    Lowe, David A.
    Kandel, Eric R.
    Yang, Jing
    Ahrens, Rosemary
    Westaway, David
    Fraser, Paul
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S137 - S137
  • [3] MEM1003, a novel, CNS-selective L-type Ca2+ channel blocker, is a potential therapeutic agent for bipolar disorder
    Murray, S. R.
    Leonard, C. J.
    Lowe, D.
    Sachs, G.
    BIPOLAR DISORDERS, 2007, 9 : 80 - 80
  • [4] The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease
    Viola, H. M.
    Macdonald, W. A.
    Tang, H.
    Hool, L. C.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (26) : 3341 - 3358
  • [5] Identification of a novel specifec modulator of the L-type Ca2+ channel Cav1.2
    Naguro, I
    Minamisawa, S
    Nishimune, Y
    Ichijo, H
    Adachi-Akahane, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 237P - 237P
  • [6] Ca2+ sensors of L-type Ca2+ channel
    Romanin, C
    Gamsjaeger, R
    Kahr, H
    Schaufler, D
    Carlson, O
    Abernethy, DR
    Soldatov, NM
    FEBS LETTERS, 2000, 487 (02) : 301 - 306
  • [7] Inhibition of T-type and L-type Ca2+ currents by aranidipine, a novel dihydropyridine Ca2+ antagonist
    Masumiya, H
    Tanaka, Y
    Tanaka, H
    Shigenobu, K
    PHARMACOLOGY, 2000, 61 (02) : 57 - 61
  • [8] Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel α1 subunits
    Wappl, E
    Mitterdorfer, J
    Glossmann, H
    Striessnig, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 12730 - 12735
  • [9] Homology model of dihydropyridine receptor:: Implications for L-type Ca2+ channel modulation by agonists and antagonists
    Zhorov, BS
    Folkman, EV
    Ananthanarayanan, VS
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 393 (01) : 22 - 41
  • [10] POSITIVE HETEROTROPIC ALLOSTERIC REGULATORS OF DIHYDROPYRIDINE BINDING INCREASE THE CA2+ AFFINITY OF THE L-TYPE CA2+ CHANNEL - STEREOSELECTIVE REVERSAL BY THE NOVEL CA2+ ANTAGONIST BM 20.1140
    STAUDINGER, R
    KNAUS, HG
    GLOSSMANN, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (17) : 10787 - 10795
12345